These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 9613972
1. Assessment of microsomal tolbutamide hydroxylation by a simple thin-layer chromatography radioactivity assay. Ludwig E, Wolfinger H, Ebner T. J Chromatogr B Biomed Sci Appl; 1998 Apr 10; 707(1-2):347-50. PubMed ID: 9613972 [Abstract] [Full Text] [Related]
2. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system. Palamanda J, Feng WW, Lin CC, Nomeir AA. Drug Metab Dispos; 2000 Jan 10; 28(1):38-43. PubMed ID: 10611138 [Abstract] [Full Text] [Related]
3. Determination of cytochrome P450 2E1 activity in microsomes by thin-layer chromatography using [2-14C]chlorzoxazone. Zerilli A, Lucas D, Berthou F, Bardou LG, Ménez JF. J Chromatogr B Biomed Appl; 1996 Feb 23; 677(1):156-60. PubMed ID: 8925089 [Abstract] [Full Text] [Related]
4. Inhibitory effect of nicotine and its metabolites on tolbutamide hydroxylation in rat liver microsomes. Leung YK, Ho JW. J Biochem Biophys Methods; 1998 Jun 11; 36(2-3):87-94. PubMed ID: 9711495 [Abstract] [Full Text] [Related]
5. Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay--inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase. Fujino H, Yamada I, Shimada S, Yoneda M. J Chromatogr B Biomed Sci Appl; 2001 Jun 05; 757(1):143-50. PubMed ID: 11419739 [Abstract] [Full Text] [Related]
6. Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: effect of psychoactive drugs on in vitro activity. Ho JW, Moody DE. Life Sci; 1993 Jun 05; 52(1):21-8. PubMed ID: 8417276 [Abstract] [Full Text] [Related]
7. Effect of albumin and cytosol on enzyme kinetics of tolbutamide hydroxylation and on inhibition of CYP2C9 by gemfibrozil in human liver microsomes. Wang JS, Wen X, Backman JT, Neuvonen PJ. J Pharmacol Exp Ther; 2002 Jul 05; 302(1):43-9. PubMed ID: 12065698 [Abstract] [Full Text] [Related]
8. Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9. Miners JO, Birkett DJ. Methods Enzymol; 1996 Jul 05; 272():139-45. PubMed ID: 8791771 [No Abstract] [Full Text] [Related]
9. Hepatic microsomal tolbutamide hydroxylation in Japanese: in vitro evidence for rapid and slow metabolizers. Chen LS, Yasumori T, Yamazoe Y, Kato R. Pharmacogenetics; 1993 Apr 05; 3(2):77-85. PubMed ID: 8518837 [Abstract] [Full Text] [Related]
10. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. Doecke CJ, Veronese ME, Pond SM, Miners JO, Birkett DJ, Sansom LN, McManus ME. Br J Clin Pharmacol; 1991 Feb 05; 31(2):125-30. PubMed ID: 2049228 [Abstract] [Full Text] [Related]
11. The characteristics of the microsomal hydroxylation of tolbutamide. Bélanger PM, St-Hilaire S. Can J Physiol Pharmacol; 1991 Mar 05; 69(3):400-5. PubMed ID: 2059905 [Abstract] [Full Text] [Related]
12. Development and validation of a simple LC method for the determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in rat microsomal medium. Zhai X, Lu Y. Pharmazie; 2013 Jan 05; 68(1):19-26. PubMed ID: 23444776 [Abstract] [Full Text] [Related]
13. Quantitative determination of tolbutamide and its metabolites in human plasma and urine by high-performance liquid chromatography and UV detection. Hansen LL, Brøsen K. Ther Drug Monit; 1999 Dec 05; 21(6):664-71. PubMed ID: 10604830 [Abstract] [Full Text] [Related]
14. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Wester MR, Lasker JM, Johnson EF, Raucy JL. Drug Metab Dispos; 2000 Mar 05; 28(3):354-9. PubMed ID: 10681382 [Abstract] [Full Text] [Related]
15. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations. Miners JO, Smith KJ, Robson RA, McManus ME, Veronese ME, Birkett DJ. Biochem Pharmacol; 1988 Mar 15; 37(6):1137-44. PubMed ID: 3355588 [Abstract] [Full Text] [Related]
16. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450. Veronese ME, McManus ME, Laupattarakasem P, Miners JO, Birkett DJ. Drug Metab Dispos; 1990 Mar 15; 18(3):356-61. PubMed ID: 1974199 [Abstract] [Full Text] [Related]
17. Thin-layer chromatography analysis of human CYP3A-catalyzed testosterone 6beta-hydroxylation. Waxman DJ, Chang TK. Methods Mol Biol; 2006 Mar 15; 320():133-41. PubMed ID: 16719384 [Abstract] [Full Text] [Related]
18. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. J Pharm Sci; 1998 Jul 15; 87(7):845-53. PubMed ID: 9649353 [Abstract] [Full Text] [Related]
20. Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors. Crewe HK, Barter ZE, Yeo KR, Rostami-Hodjegan A. Biopharm Drug Dispos; 2011 Sep 15; 32(6):303-18. PubMed ID: 21725985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]